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Abstract: KRAS mutations are found in 20% of all cancers and 40% of colorectal cancers
specifically in the G12 and G13 codons. Ras is a protein that is downstream of several Gprotein coupled receptors in a pathway integral to the regulation of programmed cell death
called apoptosis. Many cancer cells have a KRAS mutation that results in the deregulation of
these apoptotic pathways, which allows uncontrolled cell proliferation and the formation of a
tumor. One such method of this apoptosis is the release of calcium ions (Ca2+) from the
endoplasmic reticulum (ER) and mitochondria and their subsequent interaction with caspases.
Currently, research has not studied the effects of the KRASG13D mutation on the growth,
structure, and function of the colorectal cancer cells organelles, particularly the ER and
mitochondria. This research would establish the impact of the mutation on the normal calcium
storage in the colorectal cancer cell line HCT116, as well as establishing how this allele
mutation impacts the overall organelle functions. Additionally, fetal bovine serum (FBS) is
commonly added to cell cultures as it is rich in nutrients and provides the cell cultures with
many growth factors. Due to its association with rapid cell growth and high efficacy yields,
FBS is commonly utilized by industry and academia in the culturing of cells, however, is not
present for normal biological cell growth. The impact of not using FBS in cell culture has not

been widely explored, and thus the effect on cell growth rate and viability is not known. Since
FBS is so expensive, this research project will perform all colorectal cancer cell trials in
duplicate – one with FBS and one without – to determine whether cells can be cultured
successfully without the FBS. These studies will be performed via cell culture counts as well
as flow cytometry techniques with corresponding organelle stains.

